Effect of cefaperazone/sulbactam and ampicillin/sulbactam on the in vitro activity of human erythrocyte glucose-6-phosphate dehydrogenase

J Basic Clin Physiol Pharmacol. 2001;12(4):305-13. doi: 10.1515/jbcpp.2001.12.4.305.

Abstract

We investigated the effects of the antibiotic drugs cefaperazone/sulbactam and ampicillin/sulbactam on the in vitro activity of the enzyme glucose-6-phosphate dehydrogenase (G6PD). The enzyme was purified from human erythocytes using 2',5' ADP-Sepharose 4B affinity gel. The enzymatic activity was measured spectrophotometrically at 340 nm, according to the method of Beutler. The I50 values were determined from Activity % - [Drug] graphs, and the Ki constants and inhibition types for each drug were determined using Lineweaver-Burk graphs. The I50 value was 13.5 mg/ml for cefaperazone/sulbactam and 36 mg/ml for ampicillin/sulbactam. The Ki constants were 10.16 for ampicillin/sulbactam and 38.22 for cefaperazone/sulbactam. Cefaperazone/sulbactam competitively inhibited G6PD activity, whereas ampicillin/sulbactam non-competitively inhibited the activity of the enzyme.

MeSH terms

  • Ammonium Sulfate
  • Ampicillin / pharmacology*
  • Blood Proteins / chemistry
  • Cefoperazone / administration & dosage*
  • Chromatography, Affinity
  • Drug Therapy, Combination / pharmacology*
  • Electrophoresis, Polyacrylamide Gel
  • Erythrocytes / drug effects
  • Erythrocytes / enzymology*
  • Glucosephosphate Dehydrogenase / antagonists & inhibitors
  • Glucosephosphate Dehydrogenase / blood*
  • Glucosephosphate Dehydrogenase / drug effects
  • Hemolysis
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Sulbactam / administration & dosage*
  • Sulbactam / pharmacology*

Substances

  • Blood Proteins
  • sultamicillin
  • Ampicillin
  • Cefoperazone
  • Glucosephosphate Dehydrogenase
  • Sulbactam
  • Ammonium Sulfate